Evidence map›Paper›PMID 22968433›Full record

ArticleInflammation2013

Stevioside protects LPS-induced acute lung injury in mice.

Nie Yingkun, Wang Zhenyu, Lin Jing, Lu Xiuyun, Yu Huimin

Abstract read
PubMed Publisher
In one paragraph

Article in Inflammation, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
9.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Icariin AlleviatesInternational journal of molecular sciences · 2022
    Article
  5. Review
  6. Review
  7. Review
  8. Terpenoids as Potential Geroprotectors.Antioxidants (Basel, Switzerland) · 2020
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Laboratory animal research · 2017
    Article
  14. Review
  15. Article
  16. Article
  17. Rebaudioside A inhibits pentylenetetrazol-induced convulsions in rats.The Kaohsiung journal of medical sciences · 2016
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Nie YingkunDepartment of Rheumatology, the 2nd Affiliated Hospital of Harbin Medical University, Harbin Medical University, Harbin, Heilongjiang Province, 150086, People's Republic of China.
Wang Zhenyu
Lin Jing
Lu Xiuyun
Yu Huimin
Harbin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stevioside, a diterpene glycoside component of Stevia rebaudiana, has been known to exhibit anti-inflammatory properties. To evaluate the effect and the possible mechanism of stevioside in lipopolysaccharide (LPS)-induced acute lung injury, male BALB/c mice were pretreated with stevioside or dexamethasone 1 h before intranasal instillation of LPS. Seven hours later, tumor necrosis factor-α, interleukin-1β, and interleukin-6 in bronchoalveolar lavage fluid (BALF) were measured by using enzyme-linked immunosorbent assay. The number of total cells, neutrophils, and macrophages in the BALF were also determined. The right lung was excised for histological examination and analysis of myeloperoxidase activity and nitrate/nitrite content. Cyclooxygenase 2 (COX-2), inducible NO synthase (iNOS), nuclear factor-kappa B (NF-κB), inhibitory kappa B protein were detected by western blot. The results showed that stevioside markedly attenuated the LPS-induced histological alterations in the lung. Stevioside inhibited the production of pro-inflammatory cytokines and the expression of COX-2 and iNOS induced by LPS. In addition, not only was the wet-to-dry weight ratio of lung tissue significantly decreased, the number of total cells, neutrophils, and macrophages in the BALF were also significantly reduced after treatment with stevioside. Moreover, western blotting showed that stevioside inhibited the phosphorylation of IκB-α and NF-κB caused by LPS. Taken together, our results suggest that anti-inflammatory effect of stevioside against the LPS-induced acute lung injury may be due to its ability of inhibition of the NF-κB signaling pathway. Stevioside may be a promising potential therapeutic reagent for acute lung injury treatment.

Indexed as

Acute Lung InjuryAnimalsAnti-Inflammatory AgentsBronchoalveolar Lavage FluidCell CountCyclooxygenase 2DexamethasoneDiterpenes, KauraneGlucosidesI-kappa B KinaseInflammationInterleukin-1betaInterleukin-6LipopolysaccharidesLungMacrophagesAnti-Inflammatory AgentsCyclooxygenase 2DexamethasoneDiterpenes, KauraneGlucosidesI-kappa B KinaseInterleukin-1betaInterleukin-6LipopolysaccharidesNF-kappa BNitratesNitric Oxide Synthase Type IINitritesPeroxidasePtgs2 protein, mousesteviosideTumor Necrosis Factor-alpha

Identifiers

PMID22968433
OpenAlexW2025730810

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.